Completed
Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors
NCT00543101
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- Spectrum Medical Group Phoenix, Arizona, United States
- AIDS Healthcare Foundation Los Angeles, California, United States
- Orlando Immunology Center Orlando, Florida, United States
- Community Research Initiative of New England Boston, Massachusetts, United States